|
1
|
Tonelli M, Wiebe N, Culleton B, House A,
Rabbat C, Fok M, McAlister F and Garg AX: Chronic kidney disease
and mortality risk: A systematic review. J Am Soc Nephrol.
17:2034–2047. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tentori F, Blayney MJ, Albert JM,
Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T,
Pisoni RL, et al: Mortality risk for dialysis patients with
different levels of serum calcium, phosphorus, and PTH: The
dialysis outcomes and practice patterns study (DOPPS). Am J Kidney
Dis. 52:519–530. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bolasco P: Effects of the use of
Non-calcium phosphate binders in the control and outcome of
vascular calcifications: A review of clinical trials on CKD
patients. Int J Nephrol. 2011:7584502011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adragão T: Evaluation of vascular
calcifications in CKD patients. Int J Artif Organs. 32:81–86. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giachelli CM: The emerging role of
phosphate in vascular calcification. Kidney Int. 75:890–897. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lau WL and Ix JH: Clinical detection, risk
factors, and cardiovascular consequences of medial arterial
calcification: A pattern of vascular injury associated with
aberrant mineral metabolism. Semin Nephrol. 33:93–105. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Olauson H and Larsson TE: FGF23 and Klotho
in chronic kidney disease. Curr Opin Nephrol Hypertens. 22:397–404.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Yang HY and Giachelli CM: Role of
the sodium-dependent phosphate cotransporter, Pit-1, in vascular
smooth muscle cell calcification. Circ Res. 98:905–912. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Olszak IT, Poznansky MC, Evans RH, Olson
D, Kos C, Pollak MR, Brown EM and Scadden DT: Extracellular calcium
elicits a chemokinetic response from monocytes in vitro and in
vivo. J Clin Invest. 105:1299–1305. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steitz SA, Speer MY, Curinga G, Yang HY,
Haynes P, Aebersold R, Schinke T, Karsenty G and Giachelli CM:
Smooth muscle cell phenotypic transition associated with
calcification: Upregulation of Cbfa1 and downregulation of smooth
muscle lineage markers. Circ Res. 89:1147–1154. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schurgers LJ, Uitto J and Reutelingsperger
CP: Vitamin K-dependent carboxylation of matrix Gla-protein: A
crucial switch to control ectopic mineralization. Trends Mol Med.
19:217–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wallin R, Schurgers LJ and Loeser RF:
Biosynthesis of the vitamin K-dependent matrix Gla protein (MGP) in
chondrocytes: A fetuin-MGP protein complex is assembled in vesicles
shed from normal but not from osteoarthritic chondrocytes.
Osteoarthritis Cartilage. 18:1096–1103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cranenburg EC, VAN Spaendonck-Zwarts KY,
Bonafe L, Crettol Mittaz L, Rödiger LA, Dikkers FG, VAN Essen AJ,
Superti-Furga A, Alexandrakis E, Vermeer C, et al: Circulating
matrix γ-carboxyglutamate protein (MGP) species are refractory to
vitamin K treatment in a new case of Keutel syndrome. J Thromb
Haemost. 9:1225–1235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holden RM, Morton AR, Garland JS, Pavlov
A, Day AG and Booth SL: Vitamins K and D status in stages 3–5
chronic kidney disease. Clin J Am Soc Nephrol. 5:590–597. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Holden RM, Iliescu E, Morton AR and Booth
SL: Vitamin K status of Canadian peritoneal dialysis patients.
Perit Dial Int. 28:415–418. 2008.PubMed/NCBI
|
|
16
|
Westenfeld R, Krueger T, Schlieper G,
Cranenburg EC, Magdeleyns EJ, Heidenreich S, Holzmann S, Vermeer C,
Jahnen-Dechent W, Ketteler M, et al: Effect of vitamin K2
supplementation on functional vitamin K deficiency in hemodialysis
patients: A randomized trial. Am J Kidney Dis. 59:186–195. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Geleijnse JM, Vermeer C, Grobbee DE,
Schurgers LJ, Knapen MH, van der Meer IM, Hofman A and Witteman JC:
Dietary intake of menaquinone is associated with a reduced risk of
coronary heart disease: The Rotterdam Study. J Nutr. 134:3100–3105.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koitaya N, Sekiguchi M, Tousen Y, Nishide
Y, Morita A, Yamauchi J, Gando Y, Miyachi M, Aoki M, Komatsu M, et
al: Low-dose vitamin K2 (MK-4) supplementation for 12 months
improves bone metabolism and prevents forearm bone loss in
postmenopausal Japanese women. J Bone Miner Metab. 32:142–150.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Campbell JH and Campbell GR: Culture
techniques and their applications to studies of vascular smooth
muscle. Clin Sci (Lond). 85:501–513. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiba Y, Sakai H, Wachi H, Sugitani H,
Seyama Y and Misawa M: Upregulation of rhoA mRNA in bronchial
smooth muscle of antigen-induced airway hyperresponsive rats. J
Smooth Muscle Res. 39:221–228. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang S, Xu J, Feng Y, Zhang J, Cui L,
Zhang H and Bai Y: Extracellular acidosis suppresses calcification
of vascular smooth muscle cells by inhibiting calcium influx via
L-type calcium channels. Clin Exp Hypertens. 40:370–377. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu J, Bai Y, Jin J, Zhang J, Zhang S, Cui
L and Zhang H: Magnesium modulates the expression levels of
calcification-associated factors to inhibit calcification in a
time-dependent manner. Exp Ther Med. 9:1028–1034. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cherbuin N: Higher dietary intakes of
potassium, calcium and magnesium are associated with a reduced risk
of developing vascular dementia. Evid Based Ment Health. 16:262013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chaabane C, Heizmann CW and
Bochaton-Piallat ML: Extracellular S100A4 induces smooth muscle
cell phenotypic transition mediated by RAGE. Biochim Biophys Acta.
1853:2144–2157. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spronk HM, Soute BA, Schurgers LJ,
Thijssen HH, De Mey JG and Vermeer C: Tissue-specific utilization
of menaquinone-4 results in the prevention of arterial
calcification in warfarin-treated rats. J Vasc Res. 40:531–537.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wahlqvist ML, Tanaka K and Tzeng BH:
Clinical decision-making for vitamin K-1 and K-2 deficiency and
coronary artery calcification with warfarin therapy: Are diet,
factor Xa inhibitors or both the answer? Asia Pac J Clin Nutr.
22:492–496. 2013.PubMed/NCBI
|
|
27
|
Koitaya N, Ezaki J, Nishimuta M, Yamauchi
J, Hashizume E, Morishita K, Miyachi M, Sasaki S and Ishimi Y:
Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices
in postmenopausal Japanese women. J Nutr Sci Vitaminol (Tokyo).
55:15–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kerage D, Brindley DN and Hemmings DG:
Review: Novel insights into the regulation of vascular tone by
sphingosine 1-phosphate. Placenta. 35 Suppl:S86–S92. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang W, Li C, Pang L, Shi C, Guo F, Chen
A, Cao X and Wan M: Mesenchymal stem cells recruited by active TGFβ
contribute to osteogenic vascular calcification. Stem Cells Dev.
23:1392–1404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Danilevicius CF, Lopes JB and Pereira RM:
Bone metabolism and vascular calcification. Braz J Med Biol Res.
40:435–442. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin ME, Chen T, Leaf EM, Speer MY and
Giachelli CM: Runx2 expression in smooth muscle cells is required
for arterial medial calcification in mice. Am J Pathol.
185:1958–1969. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li M, Wu P, Shao J, Ke Z, Li D and Wu J:
Losartan inhibits vascular calcification by suppressing the BMP2
and Runx2 expression in rats in vivo. Cardiovasc Toxicol.
16:172–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bai Y, Zhang J, Xu J, Cui L, Zhang H and
Zhang S: Alteration of type I collagen in the radial artery of
patients with end-stage renal disease. Am J Med Sci. 349:292–297.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lieberman JR, Daluiski A and Einhorn TA:
The role of growth factors in the repair of bone. Biology and
clinical applications. J Bone Joint Surg Am. 84-A:1032–1044. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun SX, Guo HH, Zhang J, Yu B, Sun KN and
Jin QH: BMP-2 and titanium particles synergistically activate
osteoclast formation. Braz J Med Biol Res. 47:461–469. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miyazono K, Kamiya Y and Morikawa M: Bone
morphogenetic protein receptors and signal transduction. J Biochem.
147:35–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kawabata M, Imamura T and Miyazono K:
Signal transduction by bone morphogenetic proteins. Cytokine Growth
Factor Rev. 9:49–61. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sato Simoes AY, Bub GL and Campos AH:
BMP-2 and −4 produced by vascular smooth muscle cells from
atherosclerotic lesions induce monocyte chemotaxis through direct
BMPRII activation. Atherosclerosis. 235:45–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yao Y, Bennett BJ, Wang X, Rosenfeld ME,
Giachelli C, Lusis AJ and Boström KI: Inhibition of bone
morphogenetic proteins protects against atherosclerosis and
vascular calcification. Circ Res. 107:485–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cai J, Pardali E, Sánchez-Duffhues G and
Ten Dijke P: BMP signaling in vascular diseases. FEBS Lett.
586:1993–2002. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shao JS, Aly ZA, Lai CF, Cheng SL, Cai J,
Huang E, Behrmann A and Towler DA: Vascular Bmp Msx2 Wnt signaling
and oxidative stress in arterial calcification. Ann N Y Acad Sci.
1117:40–50. 2007. View Article : Google Scholar : PubMed/NCBI
|
